Profil bibliographique

Joanne Nemeth

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

12Publications signalées

1128Citations signalées

0Affiliations récentes

Les domaines associés

Amyotrophic Lateral Sclerosis ResearchMyasthenia Gravis and ThymomaPeripheral Neuropathies and DisordersNeurogenetic and Muscular Disorders ResearchPhosphodiesterase function and regulation

Les publications récentes

Accès ouvert 2020 article OpenAlex

Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension

Renato Mantegazza, Gil I. Wolfe, Srikanth Muppidi, Heinz Wiendl et autres

us, it, de (code pays fourni par la source)

80 citations Neurology

Accès ouvert 2019 article OpenAlex

Long-term efficacy and safety of eculizumab in Japanese patients with generalized myasthenia gravis: A subgroup analysis of the REGAIN open-label extension study

Hiroyuki Murai, Akiyuki Uzawa, Yasushi Suzuki, Tomihiro Imai et autres

jp, us (code pays fourni par la source)

23 citations Journal of the Neurological Sciences

Accès ouvert 2019 article OpenAlex

Eculizumab improves fatigue in refractory generalized myasthenia gravis

Henning Andersen, Renato Mantegazza, Jing Jing Wang, Fanny O’Brien et autres

dk, it, us (code pays fourni par la source)

58 citations Quality of Life Research

2017 article OpenAlex

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, Kimiaki Utsugisawa, Michael Benatar, Hiroyuki Murai et autres

us, jp, es, gb, dk, it (code pays fourni par la source)

833 citations The Lancet Neurology

2017 article OpenAlex

Community Health Simulation with a Standardized Patient: Exploring the Experience

Elizabeth K. Herron, Joanne Nemeth, Kelly Powers

us (code pays fourni par la source)

23 citations Clinical Simulation in Nursing

2017 article OpenAlex

Adaptive Design Single Center Phosphodiesterase Type 4 ( PDE4 ) Inhibitor – Ibudilast ( MN-166-ALS-1201 ) Phase 1b / 2a Clinical Trial Double - Blind ( DB ) with Open Label Extension (OLE) [ NCT02238626 ] for Amyotrophic Lateral Sclerosis ( ALS ) Patients [ 1 ] Not Requiring Non-Invasive Ventilation ( no NIV ) up to 5 years ( Early Cohort – EC ) and [ 2 ] Requiring Non-Invasive Ventilation ( NIV ) up to 10 years ( Advanced NIV Cohort – ANC ) from Disease Onset – Report of Clinical Trial DB, OLE and Post-Treatment Cessation Epochs – Per-Protocol (PP) Treatment Completion Associated with Improved Survival and Post Treatment Cessation Loss of Muscle Strength (P3.127)

Benjamin Rix Brooks, Elena Bravver, Mohammed Sanjak, Velma Langford et autres

us (code pays fourni par la source)

6 citations Neurology

Accès ouvert 2015 article OpenAlex

Randomized phase 2 trial of NP001, a novel immune regulator

Robert G. Miller, Gilbert Block, Jonathan Katz, Richard J. Barohn et autres

us (code pays fourni par la source)

98 citations Neurology Neuroimmunology & Neuroinflammation

2015 article OpenAlex

Amyotrophic Lateral Sclerosis (ALS) with Laboratory Abnormalities of Unknown Significance (LAUS) --Where Does It Begin and Where Does It End? (P4.144)

Benjamin Rix Brooks, Elena Bravver, Velma Langford, Mohamed Alwan et autres

us (code pays fourni par la source)

0 citations Neurology

2015 article OpenAlex

A Single-Center, Randomized, Double-Blind, Placebo-Controlled, Six-Month Clinical Trial Followed by an Open-Label Extension to Evaluate the Safety, Tolerability and Clinical Endpoint Responsiveness of the Phosphodiesterase Type 4 (PDE4) Inhibitor Ibudilast (MN-166) in Subjects with Amyotrophic Lateral Sclerosis (ALS) - STEP-IBUDILAST-ALS-DB-OLE-1 (S50.005)

Benjamin Rix Brooks, Elena Bravver, Mohammed Sanjak, Velma Langford et autres

us (code pays fourni par la source)

1 citation Neurology

2015 article OpenAlex

A Single-Center, Randomized, Double-Blind, Placebo-Controlled, Six-Month Clinical Trial Followed by an Open-Label Extension to Evaluate the Safety, Tolerability and Clinical Endpoint Responsiveness of the Phosphodiesterase Type 4 (PDE4) Inhibitor Ibudilast (MN-166) in Subjects with Amyotrophic Lateral Sclerosis (ALS) - STEP-IBUDILAST-ALS-DB-OLE-1 (I8-1B)

Benjamin D. Brooks, Elena Bravver, Mohammed Sanjak, Velma Langford et autres

us (code pays fourni par la source)

3 citations Neurology

2014 article OpenAlex

Serum Creatinine, a Biomarker for Muscle Mass in Amyotrophic Lateral Sclerosis (ALS), Predicts Loss of Ambulation Measured by ALS Functional Rating Scale-Revised Walking Item Score (ALSFRS-Rw) (P4.085)

Benjamin Rix Brooks, Michael J. M. Fischer, Mohammed Sanjak, Scott Holsten et autres

us, bh (code pays fourni par la source)

3 citations Neurology

2014 article OpenAlex

Safety and Tolerability of Systemic Beta-2-Adrenergic Agonist[Albuterol] as Pharmacological Therapy in Non-Invasive Ventilation[ NIV ]-supported Amyotrophic Lateral Sclerosis[ALS]Patients with Chronic Respiratory Failure (P4.079)

Benjamin Rix Brooks, Boris Kandinov, Velma Langford, Scott Lindblom et autres

us, bh (code pays fourni par la source)

0 citations Neurology

Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.